+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Beigene"

Chemotherapy Global Market Report 2024 - Product Thumbnail Image

Chemotherapy Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Gastric Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Gastric Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 550 Pages
  • Global
From
Esophageal Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Esophageal Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 250 Pages
  • Global
From
Advanced Gastric Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Advanced Gastric Carcinoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 80 Pages
  • Global
From
Advanced Hepatocellular Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Advanced Hepatocellular Carcinoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 200 Pages
  • Global
From
Myelodysplastic Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Myelodysplastic Syndrome - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 250 Pages
  • Global
From
Esophageal Squamous Cell Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Esophageal Squamous Cell Carcinoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 150 Pages
  • Global
From
Anti-CD279 (PD-1) Antibody - Pipeline Insight, 2024 - Product Thumbnail Image

Anti-CD279 (PD-1) Antibody - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
TIGIT inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

TIGIT inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Proto-oncogene protein c-bcl-2 inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Proto-oncogene protein c-bcl-2 inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Esophageal Cancer - Market Insight, Epidemiology and Market Forecast - 2032 - Product Thumbnail Image

Esophageal Cancer - Market Insight, Epidemiology and Market Forecast - 2032

  • Report
  • June 2023
  • 245 Pages
  • Global
From
Brutons Tyrosine Kinase (BTK) Inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Brutons Tyrosine Kinase (BTK) Inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 100 Pages
  • Global
From
Phosphatidylinositol 3-Kinase (PI3K) Inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Phosphatidylinositol 3-Kinase (PI3K) Inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 80 Pages
  • Global
From
Bruton's Tyrosine Kinase (BTK) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Bruton's Tyrosine Kinase (BTK) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Hematopoietic progenitor kinase 1 inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Hematopoietic progenitor kinase 1 inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Global Nasopharyngeal Cancer Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Global Nasopharyngeal Cancer Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Global Antibody Drug Conjugates Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Global Antibody Drug Conjugates Market - Forecasts from 2024 to 2029

  • Report
  • February 2024
  • 210 Pages
  • Global
From
BRAFV600 mutation (B-Raf proto-oncogene, serine/threonine kinase) Inhibiotors - Pipeline Insight, 2024 - Product Thumbnail Image

BRAFV600 mutation (B-Raf proto-oncogene, serine/threonine kinase) Inhibiotors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Global Oncology Drugs Market Size, Share & Industry Trends Analysis Report By Indication, By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy and Hormonal Therapy), By Regional Outlook and Forecast, 2023 - 2030 - Product Thumbnail Image

Global Oncology Drugs Market Size, Share & Industry Trends Analysis Report By Indication, By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy and Hormonal Therapy), By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • November 2023
  • 306 Pages
  • Global
From
Global Metastatic Cancer Drugs Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Indication, By Therapy (Targeted Therapy, Immunotherapy, Hormonal Therapy and Chemotherapy), By Regional Outlook and Forecast, 2023 - 2030 - Product Thumbnail Image

Global Metastatic Cancer Drugs Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Indication, By Therapy (Targeted Therapy, Immunotherapy, Hormonal Therapy and Chemotherapy), By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • July 2023
  • 290 Pages
  • Global
From
Loading Indicator

BeiGene is a market within the context of Oncology Drugs, which are drugs used to treat cancer. These drugs are used to target and destroy cancer cells, while minimizing damage to healthy cells. BeiGene is a biopharmaceutical company that develops and commercializes innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer. The company focuses on developing therapies that target cancer cells with precision and accuracy, while also providing a safe and effective treatment for patients. BeiGene's portfolio includes a range of drugs, including small molecules, antibodies, and other biologics. The company also has a pipeline of novel therapies in development. BeiGene is one of many companies in the Oncology Drugs market. Other companies include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more